Scheinberg DA - Search Results

1

Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia.

Maslak PG, Weiss MA, Berman E, Yao TJ, Tyson D, Golde DW, Scheinberg DA. Maslak PG, et al. Among authors: scheinberg da. Leukemia. 1996 Jan;10(1):32-9. Leukemia. 1996. PMID: 8558934 Clinical Trial.

2

A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.

Scheinberg DA, Lovett D, Divgi CR, Graham MC, Berman E, Pentlow K, Feirt N, Finn RD, Clarkson BD, Gee TS, et al. Scheinberg DA, et al. J Clin Oncol. 1991 Mar;9(3):478-90. doi: 10.1200/JCO.1991.9.3.478. J Clin Oncol. 1991. PMID: 1999719 Clinical Trial.

3

Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.

Lemoli RM, Gasparetto C, Scheinberg DA, Moore MA, Clarkson BD, Gulati SC. Lemoli RM, et al. Among authors: scheinberg da. Blood. 1991 Apr 15;77(8):1829-36. Blood. 1991. PMID: 2015406 Free article. Clinical Trial.

4

Establishment and characterization of two human myeloma cell lines secreting kappa light chains.

Eton O, Scheinberg DA, Houghton AN. Eton O, et al. Among authors: scheinberg da. Leukemia. 1989 Oct;3(10):729-35. Leukemia. 1989. PMID: 2506399

5

Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.

Tanimoto M, Scheinberg DA, Cordon-Cardo C, Huie D, Clarkson BD, Old LJ. Tanimoto M, et al. Among authors: scheinberg da. Leukemia. 1989 May;3(5):339-48. Leukemia. 1989. PMID: 2716349

6

Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia.

Scheinberg DA, Tanimoto M, McKenzie S, Strife A, Old LJ, Clarkson BD. Scheinberg DA, et al. Leukemia. 1989 Jun;3(6):440-5. Leukemia. 1989. PMID: 2725060

7

A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma.

Minasian LM, Yao TJ, Steffens TA, Scheinberg DA, Williams L, Riedel E, Houghton AN, Chapman PB. Minasian LM, et al. Among authors: scheinberg da. Cancer. 1995 May 1;75(9):2251-7. doi: 10.1002/1097-0142(19950501)75:9<2251::aid-cncr2820750910>3.0.co;2-f. Cancer. 1995. PMID: 7536122 Clinical Trial.

8

Interleukin-4 priming enhances a target for human complement-mediated cytotoxicity of CLL.

Czuczman MS, Class K, Scheinberg DA. Czuczman MS, et al. Among authors: scheinberg da. Leukemia. 1993 Jul;7(7):1020-5. Leukemia. 1993. PMID: 7686603

9

Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.

Jurcic JG, Caron PC, Miller WH Jr, Yao TJ, Maslak P, Finn RD, Larson SM, Warrell RP Jr, Scheinberg DA. Jurcic JG, et al. Among authors: scheinberg da. Leukemia. 1995 Feb;9(2):244-8. Leukemia. 1995. PMID: 7869759

10

Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid.

Vahdat L, Maslak P, Miller WH Jr, Eardley A, Heller G, Scheinberg DA, Warrell RP Jr. Vahdat L, et al. Among authors: scheinberg da. Blood. 1994 Dec 1;84(11):3843-9. Blood. 1994. PMID: 7949141 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page